Brinzolamide/TimololIn Open-Angle Glaucoma and Ocular Hypertension

被引：0
|
作者：
Jamie D. Croxtall
Lesley J. Scott
机构：
[1] Wolters Kluwer Health | Adis,
[2] Wolters Kluwer Health,undefined
来源：
Drugs & Aging | 2009年 / 26卷
关键词：
Glaucoma; Retinal Nerve Fibre Layer; Aqueous Humour; Timolol; Ocular Hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▲ Brinzolamide 1%/timolol 0.5% fixed combination (brinzolamide/timolol) is a twice-daily eyedrops suspension comprising the carbonic anhydrase-II inhibitor brinzolamide and the β-adrenergic receptor antagonist timolol.
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [31] The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension
    March, WF
    Ochsner, KI
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (02) : 136 - 143
  • [32] Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
    Topouzis, Fotis
    Goldberg, Ivan
    Bell, Katharina
    Tatham, Andrew J.
    Ridolfi, Antonia
    Hubatsch, Douglas
    Nicolela, Marcelo
    Denis, Phillipe
    Fabian Lerner, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (01) : 103 - 111
  • [33] Pulsatile ocular blood flow in primary open-angle glaucoma and ocular hypertension
    Kerr, A
    Nelson, P
    O'brien, C
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) : 1106 - 1113
  • [34] Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension
    Cengiz Akarsu
    Sevda Yılmaz
    Pelin Taner
    Ahmet Ergin
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2004, 242 : 814 - 818
  • [35] Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension
    Akarsu, C
    Yilmaz, S
    Taner, P
    Ergin, A
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (10) : 814 - 818
  • [36] Open-angle glaucoma and ocular perfusion
    Konstas, Anastasios G. P.
    Mikropoulos, Dimitrios G.
    Irkec, Murat
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (10) : 1273 - 1274
  • [37] Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
    Stewart, WC
    Day, DG
    Stewart, JA
    Holmes, KT
    Jenkins, JN
    EYE, 2004, 18 (09) : 905 - 910
  • [38] Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
    W C Stewart
    D G Day
    J A Stewart
    K T Holmes
    J N Jenkins
    Eye, 2004, 18 : 905 - 910
  • [39] Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt®) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy
    Shin, D
    SURVEY OF OPHTHALMOLOGY, 2000, 44 : S163 - S168
  • [40] Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension
    Silver, LH
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 126 (03) : 400 - 408
12345